Combe, B., Kivitz, A., Tanaka, Y., van der Heijde, D., Simon, J. A., Baraf, H. S. B., . . . Nash, P. (2021). Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: A phase III randomised clinical trial. Ann Rheum Dis.
Citação norma ChicagoCombe, Bernard, et al. "Filgotinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Phase III Randomised Clinical Trial." Ann Rheum Dis 2021.
Citação norma MLACombe, Bernard, et al. "Filgotinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Phase III Randomised Clinical Trial." Ann Rheum Dis 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.